Skip to main content
Top
Published in: Internal and Emergency Medicine 6/2019

01-09-2019 | Heart Failure | IM - COMMENTARY

The two congested failing giants: heart and liver

Author: Piero Portincasa

Published in: Internal and Emergency Medicine | Issue 6/2019

Login to get access

Excerpt

Liver disease related to the heart includes acute liver injury due to the heart, i.e., myocardial infarction, sustained arrhythmia resulting in passive congestion of the liver, chronic passive liver congestion, and “cardiac cirrhosis” [1]. Causes of congestive heart failure appear in Fig. 1 [1]. Congestive heart failure occurs when patients with advanced heart failure experience persistent and severe symptoms interfering with daily life. Advanced congestive heart failure manifests with typical symptoms (Fig. 1) and, by definition, manifestations occur despite maximum evidence-based medical therapy of heart failure, and reversible causes addressed [2, 3]. Advanced heart failure has major socio-economic burden; patients experience recurrent hospitalization, and the risk of mortality increases with the frequency of re-hospitalization [4, 5]. We reported that addressing an intensive outpatient management program to patients with chronic heart failure has beneficial long-term effects on clinical parameters, and decreases hospitalization [6].
Literature
1.
go back to reference Ford RM, Book W, Spivey JR (2015) Liver disease related to the heart. Transplant Rev 29(1):33–37 (Orlando) CrossRef Ford RM, Book W, Spivey JR (2015) Liver disease related to the heart. Transplant Rev 29(1):33–37 (Orlando) CrossRef
2.
go back to reference Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128(16):1810–1852PubMedCrossRef Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128(16):1810–1852PubMedCrossRef
3.
go back to reference Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH, Potena L, Ross HJ, Taylor DO, Verschuuren EA, Zuckermann A, International Society for Heart Lung Transplantation Infectious Diseases C, International Society for Heart Lung Transplantation Pediatric Transplantation C, International Society for Heart Lung Transplantation Heart F, Transplantation C (2016) The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transpl 35(1):1–23CrossRef Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH, Potena L, Ross HJ, Taylor DO, Verschuuren EA, Zuckermann A, International Society for Heart Lung Transplantation Infectious Diseases C, International Society for Heart Lung Transplantation Pediatric Transplantation C, International Society for Heart Lung Transplantation Heart F, Transplantation C (2016) The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transpl 35(1):1–23CrossRef
4.
go back to reference Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA, Candesartan in Heart failure: Assessment of Reduction in M, morbidity I (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116(13):1482–1487PubMedCrossRef Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA, Candesartan in Heart failure: Assessment of Reduction in M, morbidity I (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116(13):1482–1487PubMedCrossRef
5.
go back to reference Setoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154(2):260–266PubMedCrossRef Setoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154(2):260–266PubMedCrossRef
8.
go back to reference Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC (2010) Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail 3(1):59–64PubMedCrossRef Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC (2010) Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail 3(1):59–64PubMedCrossRef
9.
go back to reference Myers RP, Cerini R, Sayegh R, Moreau R, Degott C, Lebrec D, Lee SS (2003) Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology 37(2):393–400PubMedCrossRef Myers RP, Cerini R, Sayegh R, Moreau R, Degott C, Lebrec D, Lee SS (2003) Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology 37(2):393–400PubMedCrossRef
10.
go back to reference Hilscher M, Sanchez W (2016) Congestive hepatopathy. Clin Liver Dis 8(3):68–71CrossRef Hilscher M, Sanchez W (2016) Congestive hepatopathy. Clin Liver Dis 8(3):68–71CrossRef
12.
go back to reference Lefkowitch JH, Mendez L (1986) Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2(3):313–327PubMedCrossRef Lefkowitch JH, Mendez L (1986) Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2(3):313–327PubMedCrossRef
13.
go back to reference Arcidi JM Jr, Moore GW, Hutchins G (1981) Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 104(2):159PubMedPubMedCentral Arcidi JM Jr, Moore GW, Hutchins G (1981) Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 104(2):159PubMedPubMedCentral
14.
go back to reference Dai DF, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM (2014) Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. Mod Pathol 27(12):1552–1558PubMedCrossRef Dai DF, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM (2014) Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. Mod Pathol 27(12):1552–1558PubMedCrossRef
15.
go back to reference Koehne de Gonzalez AK, Lefkowitch JH (2017) Heart disease and the liver: pathologic evaluation. Gastroenterol Clin N Am 46(2):421–435CrossRef Koehne de Gonzalez AK, Lefkowitch JH (2017) Heart disease and the liver: pathologic evaluation. Gastroenterol Clin N Am 46(2):421–435CrossRef
16.
17.
18.
go back to reference Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate IICI (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120(23):2352–2357PubMedCrossRef Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate IICI (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120(23):2352–2357PubMedCrossRef
19.
go back to reference Dichtl W, Vogel W, Dunst KM, Grander W, Alber HF, Frick M, Antretter H, Laufer G, Pachinger O, Polzl G (2005) Cardiac hepatopathy before and after heart transplantation. Transpl Int 18(6):697–702PubMedCrossRef Dichtl W, Vogel W, Dunst KM, Grander W, Alber HF, Frick M, Antretter H, Laufer G, Pachinger O, Polzl G (2005) Cardiac hepatopathy before and after heart transplantation. Transpl Int 18(6):697–702PubMedCrossRef
20.
go back to reference Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K, Khawaja T, Farr M, Takayama H, Naka Y, Mancini DM, Schulze PC (2012) Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transpl 31(6):591–600CrossRef Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K, Khawaja T, Farr M, Takayama H, Naka Y, Mancini DM, Schulze PC (2012) Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transpl 31(6):591–600CrossRef
21.
go back to reference Kisloff B, Schaffer G (1976) Fulminant hepatic failure secondary to congestive heart failure. Am J Dig Dis 21(10):895–900PubMedCrossRef Kisloff B, Schaffer G (1976) Fulminant hepatic failure secondary to congestive heart failure. Am J Dig Dis 21(10):895–900PubMedCrossRef
22.
go back to reference Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y (2017) Liver stiffness assessed by fibrosis-4 index predicts mortality in patients with heart failure. Open Heart 4(1):e000598PubMedPubMedCentralCrossRef Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y (2017) Liver stiffness assessed by fibrosis-4 index predicts mortality in patients with heart failure. Open Heart 4(1):e000598PubMedPubMedCentralCrossRef
23.
go back to reference Colli A, Pozzoni P, Berzuini A, Gerosa A, Canovi C, Molteni EE, Barbarini M, Bonino F, Prati D (2010) Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology 257(3):872–878PubMedCrossRef Colli A, Pozzoni P, Berzuini A, Gerosa A, Canovi C, Molteni EE, Barbarini M, Bonino F, Prati D (2010) Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology 257(3):872–878PubMedCrossRef
24.
go back to reference Barr RG, Ferraioli G, Palmeri ML, Goodman ZD, Garcia-Tsao G, Rubin J, Garra B, Myers RP, Wilson SR, Rubens D, Levine D (2015) Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology 276(3):845–861PubMedCrossRef Barr RG, Ferraioli G, Palmeri ML, Goodman ZD, Garcia-Tsao G, Rubin J, Garra B, Myers RP, Wilson SR, Rubens D, Levine D (2015) Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology 276(3):845–861PubMedCrossRef
25.
go back to reference Chundru S, Kalb B, Arif-Tiwari H, Sharma P, Costello J, Martin DR (2013) MRI of diffuse liver disease: the common and uncommon etiologies. Diagn Interv Radiol 19(6):479–487PubMed Chundru S, Kalb B, Arif-Tiwari H, Sharma P, Costello J, Martin DR (2013) MRI of diffuse liver disease: the common and uncommon etiologies. Diagn Interv Radiol 19(6):479–487PubMed
26.
go back to reference Persico M, Palmentieri B, Vecchione R, Torella R (2002) Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. Am J Gastroenterol 97(2):491–492PubMedCrossRef Persico M, Palmentieri B, Vecchione R, Torella R (2002) Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. Am J Gastroenterol 97(2):491–492PubMedCrossRef
27.
go back to reference Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97(10):2614–2618PubMedCrossRef Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97(10):2614–2618PubMedCrossRef
28.
go back to reference Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, Investigators C (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail 11(2):170–177PubMedPubMedCentralCrossRef Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, Investigators C (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail 11(2):170–177PubMedPubMedCentralCrossRef
29.
go back to reference Cohen JA, Kaplan MM (1978) Left-sided heart failure presenting as hepatitis. Gastroenterology 74(3):583–587PubMedCrossRef Cohen JA, Kaplan MM (1978) Left-sided heart failure presenting as hepatitis. Gastroenterology 74(3):583–587PubMedCrossRef
30.
go back to reference Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr (2010) Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 160(6):1149–1155PubMedCrossRef Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr (2010) Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 160(6):1149–1155PubMedCrossRef
31.
go back to reference Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155(5):883–889PubMedCrossRef Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155(5):883–889PubMedCrossRef
32.
go back to reference Arques S, Ambrosi P (2011) Human serum albumin in the clinical syndrome of heart failure. J Card Fail 17(6):451–458PubMedCrossRef Arques S, Ambrosi P (2011) Human serum albumin in the clinical syndrome of heart failure. J Card Fail 17(6):451–458PubMedCrossRef
33.
go back to reference Giallourakis CC, Rosenberg PM, Friedman LS (2002) The liver in heart failure. Clin Liver Dis 6(4):947–967PubMedCrossRef Giallourakis CC, Rosenberg PM, Friedman LS (2002) The liver in heart failure. Clin Liver Dis 6(4):947–967PubMedCrossRef
34.
go back to reference Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140(1):111–120PubMedCrossRef Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140(1):111–120PubMedCrossRef
Metadata
Title
The two congested failing giants: heart and liver
Author
Piero Portincasa
Publication date
01-09-2019
Publisher
Springer International Publishing
Keyword
Heart Failure
Published in
Internal and Emergency Medicine / Issue 6/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02103-6

Other articles of this Issue 6/2019

Internal and Emergency Medicine 6/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.